TORC resTORbio Inc

resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases, today announced that company management will participate in two investor conferences in May:

SunTrust Robinson Humphrey 5th Annual Life Sciences SummitDate: Tuesday, May 7, 2019Location: New York, NY

Bank of America Merrill Lynch 2019 Health Care ConferenceDate: Wednesday, May 15, 2019Presentation Time: 3:55 p.m. PT (6:55 p.m. ET)Location: Las Vegas, NV

A live audio webcast of the Bank of America Merrill Lynch Health Care Conference presentation can be accessed on the Investors section of resTORbio’s website at http://ir.restorbio.com/investors. An archived replay will be available for at least 30 days following the presentation.

About resTORbioresTORbio, Inc. is a clinical stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or treat aging-related diseases. resTORbio’s lead program selectively inhibits TORC1, an evolutionarily conserved pathway that contributes to the decline in function of multiple organ systems, including the immune, cardiovascular and central nervous systems.

Investor ContactMichael SchaffzinStern Investor Relations, Inc.212-362-1200michael.schaffzin@sternir.com

Media ContactAmir KhanBiosector 2212-462-8767Amir.Khan@Syneoshealth.com